Jay Lichter Founder of Fortis Therapeutics Backed byAvalon VenturesKevin Kinsella SourcesFortis Therapeutics Closes $40 Million Series A Financing to Advance Novel Anti-CD46 Therapeutic to Treat Late-Stage Prostate Cancer and Multiple Myeloma — 2021-03 Browse all founders · Browse investors
